TNFRSF18 and autoimmune disease: Additionally, Tregs residence in the tumor microenvironment demonstrates GITR upregulation and GITR’s expression in Tregs has been extensively studied in autoimmune diseases, demonstrating its potential as an immunotherapy target having already shown promise in murine models (137, 138).